A steatosis-like model of primary mouse and human hepatocytes, showed that statins decrease the levels of PLIN5, but not other LD-associated genes via the sterol regulatory element-binding protein 2 (SREBP2) [63]. This evidence concerns the gene SREBF2 and steatosis.